M&A Archives - Page 37 of 448

1 minute read

M&A
News

Stagwell Expands in Latin America with Acquisition of Brazil-Based PROS Agency, Financial Terms Undisclosed

April 15, 7:52 AM

Stagwell (NASDAQ:STGW), the challenger network built to transform marketing, has entered into an agreement to acquire PROS Agency (PROS), a Brazil-based brand and marketing consultancy

STGW

2 minute read

Electrical Equipment Company Encore Wire Gets Wired For Takeover In €3.9B Deal

By Lekha Gupta

April 15, 7:22 AM

Encore Wire to be acquired by Prysmian for $290 per share in cash. Transaction expected to close in second half of 2024, generating ~€140 million in EBITDA synergies.

MVPA

2 minute read

Group 1 Makes Power Move in UK Market with Inchcape Auto Dealerships Buy Out

By Lekha Gupta

April 15, 6:59 AM

Group 1 Automotive to acquire Inchcape's U.K. dealerships for $439M in all-cash deal. Deal expected to close in Q3 2024.

GLRY

1 minute read

Why NextPlat Shares Are Skyrocketing Today

By Nabaparna Bhattacharya

April 12, 10:45 AM

NextPlat Corp finalizes a merger agreement with Progressive Care, with expectations of enhanced revenue streams and value creation.

NXPL

2 minute read

Paramount Shareholders Express Concerns Over Potential Skydance Media Merger: ‘Any Merger Talks That Forego Competitive Bidding…Is Averse To The Fair Market Value Of A Company’

By Benzinga Neuro

April 12, 8:53 AM

Paramount has entered into a 30-day exclusive negotiation period with Skydance, while a special committee evaluates the acquisition.

PARA

1 minute read

What’s Going On With BP Shares Premarket Friday?

By Lekha Gupta

April 12, 7:42 AM

ADNOC reportedly considered buying BP, but decided it wasn't the right fit for their strategy. BP has underperformed and is seen as a potential takeover target.

2 minute read

Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

By Vandana Singh

April 11, 4:24 PM

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

IPSC

2 minute read

Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact

By Vandana Singh

April 11, 2:47 PM

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

ALPN

1 minute read

Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal

By Vandana Singh

April 11, 12:42 PM

Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement. Acquisition expected mid-2024.

ELYM

1 minute read

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

By Vandana Singh

April 11, 12:13 PM

Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a successful equity offering, Janux is making waves in the industry. The pharmaceutical industry has seen a surge in deal activities, with acquisitions totaling $27.8 billion since the year's start.

JANX